Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9524 participants
OBSERVATIONAL
2019-05-20
2019-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of Clinical and Laboratory Findings and Diuretic Efficacy in Patients With Edematous States in the Emergency Department
NCT03967717
Detection of Exhaled Methane Levels in Hemorrhagic Shock
NCT04987411
Diagnostic Investigation and Prediction of Shock
NCT03043170
Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)
NCT03341676
Challenges in Management of Abdominal Trauma in Sohag University Hospital A Prospective Study
NCT05805852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group/Cohort
Brain Oedema induced by drugs reported to the FAERS database from inception till first quarter of 2019
Drugs, Generic
All drugs having 19 or more Brain Oedema cases reported to the FAERS database
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drugs, Generic
All drugs having 19 or more Brain Oedema cases reported to the FAERS database
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adverse event reported was included using the MedDRA term: Brain Oedema
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Peshawar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammad Ismail
Assistant Professor, Department of Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Peshawar
Peshawar, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PV-BO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.